|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operations | |||||
| Depreciation and intangibles amortization | |||||
| Amortization of intangibles | |||||
| Net recognized losses (gains) | |||||
| Amortization of issuance costs | |||||
| Change in fair value of derivative liability | |||||
| Change in value of derivative | |||||
| Provision for credit losses | |||||
| Amortization of operating lease right-of-use assets | |||||
| Stock-based compensation expense | |||||
| Stock-based compensation expense for services | |||||
| Change in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other current assets | |||||
| Accrued interest receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Unearned revenue | |||||
| Other current liabilities | |||||
| Deferred revenue | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Issuance of loan receivable | |||||
| Purchases of available-for-sale debt securities | |||||
| Proceeds from sales of available-for-sale debt securities | |||||
| Proceeds from maturities of available-for-sale debt securities | |||||
| Other recognized losses (gains) | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Notes Payable | |||||
| Proceeds raised from financial liabilities, net of issuance costs | |||||
| Payments of financial liabilities, net of interest | |||||
| Series A Preferred stock dividend payments | |||||
| Repurchase of Series A preferred stock | |||||
| Proceeds from stock issuance related to ATM facility | |||||
| Net proceeds from issuance of common stock | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing activities: | |||||
| Fair value of derivative liability reclassed to additional paid-in capital due to exercise of warrants | |||||
| Issuance of stock expensed from 2024, awarded in 2025 | |||||
| Leased assets obtained in exchange for new operating lease liabilities | |||||
| Reclassification of Series A preferred stock to mezzanine equity | |||||
| Valuation of derivative associated with convertible financial liability | |||||
| Conversion of Series A preferred to common stock | |||||
Loading...